iCAD IncICAD
Market Cap: $37.4M
About: icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Employees: 69
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 52 [Q1] → 52 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.79% less ownership
Funds ownership: 23.18% [Q1] → 21.39% (-1.79%) [Q2]
25% less capital invested
Capital invested by funds: $9.82M [Q1] → $7.38M (-$2.44M) [Q2]
47% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 19
82% less call options, than puts
Call options by funds: $7K | Put options by funds: $38K
Research analyst outlook
We haven’t received any recent analyst ratings for ICAD.